Loading…

Fluorescence and Magnetic Resonance Dual-Modality Imaging-Guided Photothermal and Photodynamic Dual-Therapy with Magnetic Porphyrin-Metal Organic Framework Nanocomposites

Phototherapy shows some unique advantages in clinical application, such as remote controllability, improved selectivity, and low bio-toxicity, than chemotherapy. In order to improve the safety and therapeutic efficacy, imaging-guided therapy seems particularly important because it integrates visible...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2017-03, Vol.7 (1), p.44153, Article 44153
Main Authors: Zhang, Hui, Li, Yu-Hao, Chen, Yang, Wang, Man-Man, Wang, Xue-Sheng, Yin, Xue-Bo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c464t-bd836d28af219b2b1f5ab7a2ae454a8dfcaecf42f7af92cd7bb87670f147df8f3
cites cdi_FETCH-LOGICAL-c464t-bd836d28af219b2b1f5ab7a2ae454a8dfcaecf42f7af92cd7bb87670f147df8f3
container_end_page
container_issue 1
container_start_page 44153
container_title Scientific reports
container_volume 7
creator Zhang, Hui
Li, Yu-Hao
Chen, Yang
Wang, Man-Man
Wang, Xue-Sheng
Yin, Xue-Bo
description Phototherapy shows some unique advantages in clinical application, such as remote controllability, improved selectivity, and low bio-toxicity, than chemotherapy. In order to improve the safety and therapeutic efficacy, imaging-guided therapy seems particularly important because it integrates visible information to speculate the distribution and metabolism of the probe. Here we prepare biocompatible core-shell nanocomposites for dual-modality imaging-guided photothermal and photodynamic dual-therapy by the in situ growth of porphyrin-metal organic framework (PMOF) on Fe 3 O 4 @C core. Fe 3 O 4 @C core was used as T 2 -weighted magnetic resonance (MR) imaging and photothermal therapy (PTT) agent. The optical properties of porphyrin were well remained in PMOF, and PMOF was therefore selected for photodynamic therapy (PDT) and fluorescence imaging. Fluorescence and MR dual-modality imaging-guided PTT and PDT dual-therapy was confirmed with tumour-bearing mice as model. The high tumour accumulation of Fe 3 O 4 @C@PMOF and controllable light excitation at the tumour site achieved efficient cancer therapy, but low toxicity was observed to the normal tissues. The results demonstrated that Fe 3 O 4 @C@PMOF was a promising dual-imaging guided PTT and PDT dual-therapy platform for tumour diagnosis and treatment with low cytotoxicity and negligible in vivo toxicity.
doi_str_mv 10.1038/srep44153
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5341151</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1903383627</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-bd836d28af219b2b1f5ab7a2ae454a8dfcaecf42f7af92cd7bb87670f147df8f3</originalsourceid><addsrcrecordid>eNplkc9O3DAQxi1UVBBw6AugSD0VKW3sOJvkUqmCLkViC6ro2Zr4T2Ka2MF2ivJKPCVml263qi-2Zr75zYw_hN7h7CPO8uqTd3KkFBf5HjokGS1SkhPyZud9gE68v8_iKUhNcf0WHZCKlIQW9BA9LfvJOum5NFwmYESygtbIoHnyQ3pr4CV8MUGfrqyAXoc5uRqg1aZNLyctpEhuOxts6KQboF8D1gExGxgiZF16F7MwzsmjDt1f_q11Yzc7bdKVDLH2xrVgYnzpYJCP1v1KvoOx3A6j9TpIf4z2FfRenrzeR-jn8uvd-bf0-uby6vzLdcrpgoa0EVW-EKQCRXDdkAarApoSCMi4MFRCcZBcUaJKUDXhomyaqlyUmcK0FKpS-RH6vOGOUzNIEX8mOOjZ6PQAbmYWNPs3Y3THWvubFTnFuMAR8P4V4OzDJH1g93ZyJs7McJ3leZyPlFH1YaPizvpootp2wBl7cZZtnY3a092Rtso_PkbB2UbgY8q00u20_I_2DCdms2Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1903383627</pqid></control><display><type>article</type><title>Fluorescence and Magnetic Resonance Dual-Modality Imaging-Guided Photothermal and Photodynamic Dual-Therapy with Magnetic Porphyrin-Metal Organic Framework Nanocomposites</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Zhang, Hui ; Li, Yu-Hao ; Chen, Yang ; Wang, Man-Man ; Wang, Xue-Sheng ; Yin, Xue-Bo</creator><creatorcontrib>Zhang, Hui ; Li, Yu-Hao ; Chen, Yang ; Wang, Man-Man ; Wang, Xue-Sheng ; Yin, Xue-Bo</creatorcontrib><description>Phototherapy shows some unique advantages in clinical application, such as remote controllability, improved selectivity, and low bio-toxicity, than chemotherapy. In order to improve the safety and therapeutic efficacy, imaging-guided therapy seems particularly important because it integrates visible information to speculate the distribution and metabolism of the probe. Here we prepare biocompatible core-shell nanocomposites for dual-modality imaging-guided photothermal and photodynamic dual-therapy by the in situ growth of porphyrin-metal organic framework (PMOF) on Fe 3 O 4 @C core. Fe 3 O 4 @C core was used as T 2 -weighted magnetic resonance (MR) imaging and photothermal therapy (PTT) agent. The optical properties of porphyrin were well remained in PMOF, and PMOF was therefore selected for photodynamic therapy (PDT) and fluorescence imaging. Fluorescence and MR dual-modality imaging-guided PTT and PDT dual-therapy was confirmed with tumour-bearing mice as model. The high tumour accumulation of Fe 3 O 4 @C@PMOF and controllable light excitation at the tumour site achieved efficient cancer therapy, but low toxicity was observed to the normal tissues. The results demonstrated that Fe 3 O 4 @C@PMOF was a promising dual-imaging guided PTT and PDT dual-therapy platform for tumour diagnosis and treatment with low cytotoxicity and negligible in vivo toxicity.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/srep44153</identifier><identifier>PMID: 28272454</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>59/57 ; 631/67/1059/602 ; 631/67/2321 ; 639/638/11/942 ; 639/638/298/920 ; 639/638/298/921 ; 64/60 ; Animals ; Breast Neoplasms - diagnostic imaging ; Breast Neoplasms - therapy ; Cancer ; Chemotherapy ; Contrast Media - chemistry ; Contrast Media - pharmacology ; Cytotoxicity ; Female ; Fluorescence ; Humanities and Social Sciences ; Humans ; Hyperthermia, Induced - methods ; Magnetic resonance imaging ; Magnetic Resonance Imaging - methods ; Magnetite Nanoparticles - chemistry ; Magnetite Nanoparticles - therapeutic use ; MCF-7 Cells ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; multidisciplinary ; Nanocomposites ; Optical Imaging - methods ; Optical properties ; Photochemotherapy - methods ; Photodynamic therapy ; Phototherapy ; Science ; Toxicity ; Tumors ; Xenograft Model Antitumor Assays</subject><ispartof>Scientific reports, 2017-03, Vol.7 (1), p.44153, Article 44153</ispartof><rights>The Author(s) 2017</rights><rights>Copyright Nature Publishing Group Mar 2017</rights><rights>Copyright © 2017, The Author(s) 2017 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-bd836d28af219b2b1f5ab7a2ae454a8dfcaecf42f7af92cd7bb87670f147df8f3</citedby><cites>FETCH-LOGICAL-c464t-bd836d28af219b2b1f5ab7a2ae454a8dfcaecf42f7af92cd7bb87670f147df8f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1903383627/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1903383627?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25730,27900,27901,36988,44565,53765,53767,75095</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28272454$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Hui</creatorcontrib><creatorcontrib>Li, Yu-Hao</creatorcontrib><creatorcontrib>Chen, Yang</creatorcontrib><creatorcontrib>Wang, Man-Man</creatorcontrib><creatorcontrib>Wang, Xue-Sheng</creatorcontrib><creatorcontrib>Yin, Xue-Bo</creatorcontrib><title>Fluorescence and Magnetic Resonance Dual-Modality Imaging-Guided Photothermal and Photodynamic Dual-Therapy with Magnetic Porphyrin-Metal Organic Framework Nanocomposites</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Phototherapy shows some unique advantages in clinical application, such as remote controllability, improved selectivity, and low bio-toxicity, than chemotherapy. In order to improve the safety and therapeutic efficacy, imaging-guided therapy seems particularly important because it integrates visible information to speculate the distribution and metabolism of the probe. Here we prepare biocompatible core-shell nanocomposites for dual-modality imaging-guided photothermal and photodynamic dual-therapy by the in situ growth of porphyrin-metal organic framework (PMOF) on Fe 3 O 4 @C core. Fe 3 O 4 @C core was used as T 2 -weighted magnetic resonance (MR) imaging and photothermal therapy (PTT) agent. The optical properties of porphyrin were well remained in PMOF, and PMOF was therefore selected for photodynamic therapy (PDT) and fluorescence imaging. Fluorescence and MR dual-modality imaging-guided PTT and PDT dual-therapy was confirmed with tumour-bearing mice as model. The high tumour accumulation of Fe 3 O 4 @C@PMOF and controllable light excitation at the tumour site achieved efficient cancer therapy, but low toxicity was observed to the normal tissues. The results demonstrated that Fe 3 O 4 @C@PMOF was a promising dual-imaging guided PTT and PDT dual-therapy platform for tumour diagnosis and treatment with low cytotoxicity and negligible in vivo toxicity.</description><subject>59/57</subject><subject>631/67/1059/602</subject><subject>631/67/2321</subject><subject>639/638/11/942</subject><subject>639/638/298/920</subject><subject>639/638/298/921</subject><subject>64/60</subject><subject>Animals</subject><subject>Breast Neoplasms - diagnostic imaging</subject><subject>Breast Neoplasms - therapy</subject><subject>Cancer</subject><subject>Chemotherapy</subject><subject>Contrast Media - chemistry</subject><subject>Contrast Media - pharmacology</subject><subject>Cytotoxicity</subject><subject>Female</subject><subject>Fluorescence</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Hyperthermia, Induced - methods</subject><subject>Magnetic resonance imaging</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Magnetite Nanoparticles - chemistry</subject><subject>Magnetite Nanoparticles - therapeutic use</subject><subject>MCF-7 Cells</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Nude</subject><subject>multidisciplinary</subject><subject>Nanocomposites</subject><subject>Optical Imaging - methods</subject><subject>Optical properties</subject><subject>Photochemotherapy - methods</subject><subject>Photodynamic therapy</subject><subject>Phototherapy</subject><subject>Science</subject><subject>Toxicity</subject><subject>Tumors</subject><subject>Xenograft Model Antitumor Assays</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNplkc9O3DAQxi1UVBBw6AugSD0VKW3sOJvkUqmCLkViC6ro2Zr4T2Ka2MF2ivJKPCVml263qi-2Zr75zYw_hN7h7CPO8uqTd3KkFBf5HjokGS1SkhPyZud9gE68v8_iKUhNcf0WHZCKlIQW9BA9LfvJOum5NFwmYESygtbIoHnyQ3pr4CV8MUGfrqyAXoc5uRqg1aZNLyctpEhuOxts6KQboF8D1gExGxgiZF16F7MwzsmjDt1f_q11Yzc7bdKVDLH2xrVgYnzpYJCP1v1KvoOx3A6j9TpIf4z2FfRenrzeR-jn8uvd-bf0-uby6vzLdcrpgoa0EVW-EKQCRXDdkAarApoSCMi4MFRCcZBcUaJKUDXhomyaqlyUmcK0FKpS-RH6vOGOUzNIEX8mOOjZ6PQAbmYWNPs3Y3THWvubFTnFuMAR8P4V4OzDJH1g93ZyJs7McJ3leZyPlFH1YaPizvpootp2wBl7cZZtnY3a092Rtso_PkbB2UbgY8q00u20_I_2DCdms2Y</recordid><startdate>20170308</startdate><enddate>20170308</enddate><creator>Zhang, Hui</creator><creator>Li, Yu-Hao</creator><creator>Chen, Yang</creator><creator>Wang, Man-Man</creator><creator>Wang, Xue-Sheng</creator><creator>Yin, Xue-Bo</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20170308</creationdate><title>Fluorescence and Magnetic Resonance Dual-Modality Imaging-Guided Photothermal and Photodynamic Dual-Therapy with Magnetic Porphyrin-Metal Organic Framework Nanocomposites</title><author>Zhang, Hui ; Li, Yu-Hao ; Chen, Yang ; Wang, Man-Man ; Wang, Xue-Sheng ; Yin, Xue-Bo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-bd836d28af219b2b1f5ab7a2ae454a8dfcaecf42f7af92cd7bb87670f147df8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>59/57</topic><topic>631/67/1059/602</topic><topic>631/67/2321</topic><topic>639/638/11/942</topic><topic>639/638/298/920</topic><topic>639/638/298/921</topic><topic>64/60</topic><topic>Animals</topic><topic>Breast Neoplasms - diagnostic imaging</topic><topic>Breast Neoplasms - therapy</topic><topic>Cancer</topic><topic>Chemotherapy</topic><topic>Contrast Media - chemistry</topic><topic>Contrast Media - pharmacology</topic><topic>Cytotoxicity</topic><topic>Female</topic><topic>Fluorescence</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Hyperthermia, Induced - methods</topic><topic>Magnetic resonance imaging</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Magnetite Nanoparticles - chemistry</topic><topic>Magnetite Nanoparticles - therapeutic use</topic><topic>MCF-7 Cells</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Nude</topic><topic>multidisciplinary</topic><topic>Nanocomposites</topic><topic>Optical Imaging - methods</topic><topic>Optical properties</topic><topic>Photochemotherapy - methods</topic><topic>Photodynamic therapy</topic><topic>Phototherapy</topic><topic>Science</topic><topic>Toxicity</topic><topic>Tumors</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Hui</creatorcontrib><creatorcontrib>Li, Yu-Hao</creatorcontrib><creatorcontrib>Chen, Yang</creatorcontrib><creatorcontrib>Wang, Man-Man</creatorcontrib><creatorcontrib>Wang, Xue-Sheng</creatorcontrib><creatorcontrib>Yin, Xue-Bo</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Hui</au><au>Li, Yu-Hao</au><au>Chen, Yang</au><au>Wang, Man-Man</au><au>Wang, Xue-Sheng</au><au>Yin, Xue-Bo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fluorescence and Magnetic Resonance Dual-Modality Imaging-Guided Photothermal and Photodynamic Dual-Therapy with Magnetic Porphyrin-Metal Organic Framework Nanocomposites</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2017-03-08</date><risdate>2017</risdate><volume>7</volume><issue>1</issue><spage>44153</spage><pages>44153-</pages><artnum>44153</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Phototherapy shows some unique advantages in clinical application, such as remote controllability, improved selectivity, and low bio-toxicity, than chemotherapy. In order to improve the safety and therapeutic efficacy, imaging-guided therapy seems particularly important because it integrates visible information to speculate the distribution and metabolism of the probe. Here we prepare biocompatible core-shell nanocomposites for dual-modality imaging-guided photothermal and photodynamic dual-therapy by the in situ growth of porphyrin-metal organic framework (PMOF) on Fe 3 O 4 @C core. Fe 3 O 4 @C core was used as T 2 -weighted magnetic resonance (MR) imaging and photothermal therapy (PTT) agent. The optical properties of porphyrin were well remained in PMOF, and PMOF was therefore selected for photodynamic therapy (PDT) and fluorescence imaging. Fluorescence and MR dual-modality imaging-guided PTT and PDT dual-therapy was confirmed with tumour-bearing mice as model. The high tumour accumulation of Fe 3 O 4 @C@PMOF and controllable light excitation at the tumour site achieved efficient cancer therapy, but low toxicity was observed to the normal tissues. The results demonstrated that Fe 3 O 4 @C@PMOF was a promising dual-imaging guided PTT and PDT dual-therapy platform for tumour diagnosis and treatment with low cytotoxicity and negligible in vivo toxicity.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>28272454</pmid><doi>10.1038/srep44153</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2017-03, Vol.7 (1), p.44153, Article 44153
issn 2045-2322
2045-2322
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5341151
source Publicly Available Content Database; PubMed Central; Free Full-Text Journals in Chemistry; Springer Nature - nature.com Journals - Fully Open Access
subjects 59/57
631/67/1059/602
631/67/2321
639/638/11/942
639/638/298/920
639/638/298/921
64/60
Animals
Breast Neoplasms - diagnostic imaging
Breast Neoplasms - therapy
Cancer
Chemotherapy
Contrast Media - chemistry
Contrast Media - pharmacology
Cytotoxicity
Female
Fluorescence
Humanities and Social Sciences
Humans
Hyperthermia, Induced - methods
Magnetic resonance imaging
Magnetic Resonance Imaging - methods
Magnetite Nanoparticles - chemistry
Magnetite Nanoparticles - therapeutic use
MCF-7 Cells
Mice
Mice, Inbred BALB C
Mice, Nude
multidisciplinary
Nanocomposites
Optical Imaging - methods
Optical properties
Photochemotherapy - methods
Photodynamic therapy
Phototherapy
Science
Toxicity
Tumors
Xenograft Model Antitumor Assays
title Fluorescence and Magnetic Resonance Dual-Modality Imaging-Guided Photothermal and Photodynamic Dual-Therapy with Magnetic Porphyrin-Metal Organic Framework Nanocomposites
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T09%3A00%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fluorescence%20and%20Magnetic%20Resonance%20Dual-Modality%20Imaging-Guided%20Photothermal%20and%20Photodynamic%20Dual-Therapy%20with%20Magnetic%20Porphyrin-Metal%20Organic%20Framework%20Nanocomposites&rft.jtitle=Scientific%20reports&rft.au=Zhang,%20Hui&rft.date=2017-03-08&rft.volume=7&rft.issue=1&rft.spage=44153&rft.pages=44153-&rft.artnum=44153&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/srep44153&rft_dat=%3Cproquest_pubme%3E1903383627%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c464t-bd836d28af219b2b1f5ab7a2ae454a8dfcaecf42f7af92cd7bb87670f147df8f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1903383627&rft_id=info:pmid/28272454&rfr_iscdi=true